Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000635057 | SCV000756435 | likely benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-01-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004782481 | SCV005394775 | uncertain significance | not specified | 2024-09-24 | criteria provided, single submitter | clinical testing | Variant summary: CACNA1H c.2255C>T (p.Pro752Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 234162 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in CACNA1H causing Idiopathic Generalized Epilepsy, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.2255C>T in individuals affected with Idiopathic Generalized Epilepsy and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 529598). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |